What we do? We develop digital therapeutics to address unmet medical needs in hematology and oncology. How it works? First we build networks of doctors and patients designed to track, predict and prevent disease. Second, we validate the safety and efficacy of our interventions in pivotal clinical studies to obtain regulatory clearance (SaMD). Finally, we aim to commercialize our products as prescription digital therapeutics (DTx). Where are we now? Today, we are the standard in digital hematology: Our hemophilia network covers 33% of all patients and providers in the US. We bested 20+ competitors, including several Fortune 500 companies. Our clients include: Sanofi, Bayer, Novo Nordisk, Biogen, and Roche.
Empowering every doctor and every patient to participate in research
Bunkerhill Health is the commercialization engine for healthcare AI
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
Personalized drug discovery for blood cancer.
Engineering living therapies for pets and their people
Kernal is creating mRNA 2.0 therapies that work in specific cells
Software for pharmacies to move beyond dispensing
Modern medical billing
AI-supported M&A Intelligence for BioPharma
DaaS (Diagnostics -as-a-Service) company for India, ME and SEA
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS